Immunogenicity & Safety of GSK's Influenza Vaccine 1557484A Given to Adults Aged ≥18 Years

NCT00616928 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

4561

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted
BIOLOGICAL: Placebo

Sponsor

GlaxoSmithKline